Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biologics
Biotech
Cell therapy biotech Appia shuts down as funding runs dry
The preclinical company reached the cusp of filing an IND application before running out of cash.
Darren Incorvaia
Aug 25, 2025 5:55pm
Arena BioWorks, 19 months after splashy launch, lays off staff
Aug 22, 2025 10:05am
Fierce Pharma
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
Aug 21, 2025 10:52am
Krystal discontinues melanoma study after FDA's Replimune rebuff
Aug 21, 2025 10:50am
Kite sails into in vivo CAR-T space via $350M Interius buyout
Aug 21, 2025 9:59am
After 'complete standstill,' biotech market reaches new normal
Aug 20, 2025 11:04am
